RSS
seed funding
Biotech secures seed funding to progress new treatments for rare metabolic disorders
Biotech company, Azafaros, has secured seed funding — with BioGeneration Ventures (BGV) as the founding investor — to develop new treatments aimed at addressing unmet medical needs in the field of rare metabolic disorders. Read more
